Understanding the molecular basis of Congenital Hyperinsulinism due to autosomal dominant ABCC8 and KCNJ11 mutations
Background: Congenital Hyperinsulinism (CHI) is a rare heterogeneous disease characterised by unregulated insulin secretion. A prominent feature of CHI is severe hypoglycaemia which presents during the neonatal period. Immediate medical attention is required to prevent permanent neurological damage....
Main Author: | Nessa, A. |
---|---|
Published: |
University College London (University of London)
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.631956 |
Similar Items
-
Physiology and pharmacology of glucagon and somatostatin in children with congenital hyperinsulinism
by: Shah, P. H.
Published: (2017) -
The role of MTOR pathway and growth factors as revealed by gene expression profiling in diffuse congenital hyperinsulinism
by: Karuppanan Senniappan, S.
Published: (2014) -
Understanding the genetic basis of diabetes mellitus and sensorineural deafness
by: Sherif, M. M. A.
Published: (2015) -
Congenital muscular dystrophy in 2010
by: Clement, E.
Published: (2011) -
The molecular basis of childhood nephrotic syndrome
by: Koziell, A. B.
Published: (2007)